RecruitingPhase 1NCT05967299

Study of Intravenous ZMA001 in Healthy Subjects

Studying Heritable pulmonary arterial hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator
Jason M Elinoff, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Intervention
Placebo Cohort 1 (1.5 mg/kg/dose) only(other)
Enrollment
96 enrolled
Eligibility
18-60 years · All sexes
Timeline
20232027

Study locations (1)

Collaborators

Zymedi, Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05967299 on ClinicalTrials.gov

Other trials for Heritable pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

See all trials for Heritable pulmonary arterial hypertension

← Back to all trials